Vesta Medical VestaBlate uterine balloon system begins U.S. clinicals.
This article was originally published in The Gray Sheet
Executive Summary
VESTA MEDICAL VESTABLATE UTERINE BALLOON SYSTEM U.S. CLINICALS begin with first treatment Jan. 31, the Mountain View, California-based firm reports. Under an investigational device exemption approved by FDA in September 1995, Vesta is studying the device as a non-surgical alternative to hysterectomy for the treatment of excessive menstrual bleeding (menorrhagia). Vesta plans to treat 180 patients at up to 12 clinical sites in the U.S.